Academic Jobs - Home of Higher Ed Logo

Rate My Professor Hannah Moore

Curtin University

Ratings & reviews

4.08/20/2025

Brings enthusiasm to every interaction.

4.05/21/2025

Creates a collaborative learning environment.

4.02/27/2025

Encourages students to think independently.

5.02/10/2025

Encourages creative and innovative thinking.

Taught by or worked with Hannah?

Add your rating. It takes about 30 seconds.

About Hannah

Professor Hannah Moore is a Professor in the School of Population Health within the Faculty of Health Sciences at Curtin University. She holds joint appointments as Theme Head of Infectious Diseases and Head of Infectious Diseases Research at The Kids Research Institute Australia, where she co-leads the Infectious Diseases Epidemiology team, and as Program Head of Infections and Vaccines and Co-Head of the Infectious Disease Epidemiology team at the Telethon Kids Institute's Wesfarmers Centre of Vaccines and Infectious Diseases. Her academic qualifications include a PhD in Epidemiology from the University of Western Australia (2011), focusing on epidemiological perspectives of acute lower respiratory infections in young Western Australian Aboriginal and non-Aboriginal children; a Graduate Diploma in Clinical Epidemiology from the University of Western Australia (2006); a BSc (Hons 1) in Biomedical Science from Murdoch University (2003), examining patterns of morbidity and health service utilisation in Rett Syndrome; and a BSc in Biomedical Sciences, Mathematics, and Statistics from Murdoch University (2002). Professor Moore's research employs population-based record linkage and epidemiological methods to quantify the burden of paediatric infectious diseases, particularly respiratory syncytial virus (RSV), evaluate vaccine effectiveness, and inform prevention strategies. Her work has directly influenced Western Australia's first comprehensive RSV infant immunisation program and contributed to state and national influenza vaccination policies. She holds activity lead positions in the Strep A Vaccine Global Consortium (SAVAC 2.0) and has secured over $19 million in competitive grants, including a five-year Stan Perron Charitable Foundation Fellowship (2021–2025) and WA Emerging Leader Fellowship (2022–2024).